Where we are
One or more speakers from all partners will present the recents developments in the framework of the project
Why is Nanobright a unique opportunity for brain tumors
Speakers: Manuel Valiente and Mariam Al-Masmudi
Experimental characterization of tapered nanofibers with plasmonic structures
Speaker: Chengjie Ding
Where we are
-
15:00 - 15:20 CNIO - Manuel Valiente
-
15:20 - 15:40 IIT - Ferruccio Pisanello, Cristian Ciracì
-
15:40 - 16:00 CNRS - Marianna Amato
-
16:00 - 16:20 CSIC - Liset M. De La Prida
ABSTRACTS:
CNIO: The Brain Metastasis Group (CNIO) has the goal of providing the known-how for applying clinically relevant questions to interrogate experimental and human-derived brain tumors. We are specifically interested in exploiting diagnostic and therapeutic opportunities within Nanobright to challenge the lethality of this unmet clinical need in oncology.
IIT: We will describe recent results and related issues concerning (i) the numerical estimation of the electromagneic field profile along tapered fibers, (ii) the spatial-sective activation of a subset of hotspots on flat-cleaved fibers
CNRS: We will present a technique to design and fabricate ultrahigh trasmission optical nanofibers characterized by a highly confined and intense evanescent field at the nanofiber surface. With this compact optical platform it is possibile to couple light with small structures deposited on the surface, in order to study the interaction between the guided electromagnetic modes and matter.
CSIC: Extracellular mapping of brain metastasis and TBI. We will discuss rhythmopathies accompanying brain metastasis and traumatic brain injury (TBI), and how they can be integrated with multifunctional neural implants for better delination of epileptogenic territories.
Raman from tapered fibers
-
15:30 - 16:00 Webinar: Filippo Pisano
-
16:00 - 16:30 Progress report: Filippo Pisano
ABSTRACT: TBA
NanoBRIGHT updates from CSIC
-
15:30 - 16:00 Webinar: Liset De La Prida
-
16:00 - 16:30 Progress report: Liset De La Prida
ABSTRACT: TBA
Why is Nanobright a unique opportunity for brain tumors
-
15:30 - 16:00 Webinar: Manuel Valiente "Why is Nanobright a unique opportunity for brain tumors"
-
16:00 - 16:30 Progress report: Mariam Al-Masmudi "Applying light to improve drug access to the brain and to classify different tumor entities"
ABSTRACT: Upon diagnosis of a brain tumor (primary or secondary) patients face a dismal prognosis. Very aggressive treatments including surgery are frequently applied with palliative rather than curative results since systemic therapies do not reach significant results in the majority of patients. Decreasing the aggressive management by limiting the need of biopsies and facilitating the access of the many drugs that have been proved efficacious against cancer out of the brain might offer new opportunities. Our contribution to Nanobright is intended to apply light using specific probes develop within the consortium to provide clinically relevant applications for these technologies using advanced tumor models as well as human samples.
Experimental characterization of tapered nanofibers with plasmonic structures
-
15:30 - 16:00 Webinar: Chengjie Ding
-
16:00 - 16:30 Progress Report: Chengjie Ding
ABSTRACT: TBA
Spatial-selective plasmonic endoscope with thin MMF
-
15:30 - 16:00 Webinar: Liam Conlard
-
16:00 - 16:30 Progress report: Liam Conlard
ABSTRACT: TBA
